Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 6:4:1373689.
doi: 10.3389/fdsfr.2024.1373689. eCollection 2024.

Editorial: Traditional and innovative approaches for signal detection

Affiliations
Editorial

Editorial: Traditional and innovative approaches for signal detection

Marco Tuccori et al. Front Drug Saf Regul. .
No abstract available

Keywords: artificial intelligence; disproportionality analysis; natural language processing; pharmacovigilance; real world evidence (RWE); signal detection; signal management.

PubMed Disclaimer

Conflict of interest statement

AB is an employee of GlaxoSmithKline (GSK) and holds shares and stock options. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Traditional and innovative approaches for signal detection

References

    1. Bate A. (2017). Guidance to reinforce the credibility of health care database studies and ensure their appropriate impact. Pharmacoepidemiol Drug Saf. 26 (9), 1013–1017. 10.1002/pds.4305 - DOI - PubMed
    1. Bergman E., Dürlich L., Arthurson V., Sundström A., Larsson M., Bhuiyan S., et al. (2023). BERT based natural language processing for triage of adverse drug reaction reports shows close to human-level performance. PLOS Digit. Heal 2 (12), e0000409. 10.1371/journal.pdig.0000409 - DOI - PMC - PubMed
    1. Coloma P. M., Trifirò G., Patadia V., Sturkenboom M. (2013). Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture? Drug Saf. 36 (3), 183–197. 10.1007/s40264-013-0018-x - DOI - PubMed
    1. Cortes B., Jambon-Barbara C., Cracowski J.-L., Khouri C. (2023). Validity, relevance and interpretation of pharmacovigilance disproportionality analyses. Bone 170, 116685. 10.1016/j.bone.2023.116685 - DOI - PubMed
    1. Coste A., Wong A., Bokern M., Bate A., Douglas I. J. (2023). Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review. Pharmacoepidemiol Drug Saf. 32 (1), 28–43. 10.1002/pds.5548 - DOI - PMC - PubMed

Publication types